Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06061315Not ApplicableCompleted

Effect of Collagen Peptides, in Combination With Resistance Training, on Body Composition and Muscle Strength in Untrained Men

Role: collaborator

NCT07456449Not ApplicableRecruiting

Collagen Peptides and Cellular Aging

Role: collaborator

NCT06689761Not ApplicableEnrolling By Invitation

Influence of Specific Collagen Peptides on Training-Induced Metabolic and Biomechanical Adaptations of Skeletal Muscle

Role: collaborator

NCT05220371Not ApplicableCompleted

Influence of Specific Collagen Peptides on Recovery After Exercise Induced Muscle Damage

Role: collaborator

All 4 trials loaded